The United States Pharmacopoeia 2025 annual drug shortage report documents a reduction in the number of drug shortages but an increase in the time during which drugs remain in short supply.
FDA approves labeling changes for Haleon’s OTC weight loss drug alli to warn of the rare risk of kidney injury associated with its use.
The United States Pharmacopoeia 2025 annual drug shortage report documents a reduction in the number of drug shortages but an increase in the time during which drugs remain in short supply.
FDA approves labeling changes for Haleon’s OTC weight loss drug alli to warn of the rare risk of kidney injury associated with its use.
Three Akin Gump attorneys highlight some changes in a 2026 FDA draft guidance on communicating healthcare economic information from its 2018 final guidance predecessor.
FDA sends an untitled letter to contract manufacturer Formulated Solutions, citing GMP violations related to component testing and quality oversight at the company's Largo, FL facility.
